The featured speaker for this post is Dr Olivier Heudi, Head, Translational Sciences, Norvatis Institute for Biomedical Research, Switzerland. On the 21st of March, Dr Heudi will be making at presentation at Drug Discovery World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012, held at Marina Bay Sands, Singapore.
Dr Heudi obtained his diploma of advanced studies in physiology and pharmacology at Pasteur Institute Paris (France) in 1995 and his Ph.D. in life Sciences at the University of Angers France in 1999. He previously gained experience in the analytical field at GSK Stevenage (UK) where he has implemented LC-ICPMS and LC-MS/MS for the quantification of peptide in biological fluids and at NestlÃ© Lausanne (CH) where he developed LC-MS/MS methods for the identification and quantification of vitamins and natural ingredients in food products and in raw materials. Then he joined Novartis Institute for Tropical Diseases (Singapore) where he was leading the bioanalytical laboratory. In December 2006, Olivier was appointed as laboratory head in the DMPK group where he is now working on LC-MS/MS method development and implementation for the quantification of monoclonal antibodies, oligonucleotides and small molecules in biological matrixes. Olivier is active as reviewer in several analytical papers and has great interest in new technologies with special attention on large molecules.
Here is what Dr Heudi will be sharing on:
High throughput quantitative analysis of new chemical entities in biological fluids: can we achieve a 10 seconds analysis time per sample?1. High throughput quantitative analysis in biological fluids
2. Sample preparation protein precipitation and Solid phase extraction
3. Laser diode thermal desorption and APCI-MS